# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Bausch Health misses Q1 EPS estimates at 59 cents, despite a revenue increase of 11%.
Bausch Health Companies (NYSE:BHC) reported quarterly sales of $2.153 which missed the analyst consensus estimate of $2.156 bil...
RBC Capital analyst Douglas Miehm maintains Bausch Health Companies (NYSE:BHC) with a Sector Perform and lowers the price ta...
RBC Capital analyst Douglas Miehm reiterates Bausch Health Companies (NYSE:BHC) with a Sector Perform and maintains $12 pric...
- Reuters Citing U.S. Appeals Court
https://storage.courtlistener.com/recap/gov.uscourts.cafc.19114/gov.uscourts.cafc.19114.71.0.pdf
Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that its topical prescrip...